BBS-Bioactive Bone Substitutes Oyj (HLSE:BONEHU0223) - Stock Price, News & Analysis

BONEHU0223 Stock Overview

A biomedical technology company, develops, manufactures, and commercializes bioactive medical devices and implants for orthopedic surgery in Finland.

About the company

BONEHU0223 fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	2/6
Past Performance	0/6
Financial Health	2/6
Dividends	0/6

Rewards

Revenue is forecast to grow 78.76% per year

Risk Analysis

Does not have a meaningful market cap (€6M)

Earnings are forecast to decline by an average of 10.3% per year for the next 3 years

Makes less than USD$1m in revenue (€0)

Shareholders have been substantially diluted in the past year

+ 2 more risks

BBS-Bioactive Bone Substitutes Oyj Competitors

Roquefort Therapeutics

LSE:ROQ

UK£4.6m

Anatara Lifesciences

ASX:ANR

AU$12.9m

Xenetic Biosciences

NasdaqCM:XBIO

US$5.9m

PCI Biotech Holding

OB:PCIB

NOK 66.7m

Price History & Performance

Summary of all time highs, changes and price drops for BBS-Bioactive Bone Substitutes Oyj
Historical stock prices
Current Share Price	€0.0002
52 Week High	€0.14
52 Week Low	€0.0002
Beta	-0.25
11 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	-94.44%

Recent updates

Shareholder Returns

	BONEHU0223	FI Biotechs	FI Market
7D	-92.3%	-1.8%	0.9%
1Y	n/a	-1.0%	-3.5%

Return vs Industry: Insufficient data to determine how BONEHU0223 performed against the Finnish Biotechs industry.

Return vs Market: Insufficient data to determine how BONEHU0223 performed against the Finnish Market.

Price Volatility

Is BONEHU0223's price volatile compared to industry and market?
BONEHU0223 volatility
BONEHU0223 Average Weekly Movement	n/a
Biotechs Industry Average Movement	7.7%
Market Average Movement	4.3%
10% most volatile stocks in FI Market	7.2%
10% least volatile stocks in FI Market	2.6%

Stable Share Price: BONEHU0223's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine BONEHU0223's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1991	22	Juliusz Rakowskias	www.bbs-artebone.fi

BBS-Bioactive Bone Substitutes Oyj, a biomedical technology company, develops, manufactures, and commercializes bioactive medical devices and implants for orthopedic surgery in Finland. It offers ARTEBONE, an orthobiological product based on tricalcium phosphate and natural spectrum of bone proteins used primarily for the treatment of bone defects and healing problems in extremities, such as foot and ankle. The company was incorporated in 1991 and is headquartered in Oulu, Finland.

BBS-Bioactive Bone Substitutes Oyj Fundamentals Summary

How do BBS-Bioactive Bone Substitutes Oyj's earnings and revenue compare to its market cap?
BONEHU0223 fundamental statistics
Market cap	€5.77m
Earnings (TTM)	-€3.08m
Revenue (TTM)	n/a

0.0x

P/S Ratio

-1.9x

P/E Ratio

Is BONEHU0223 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BONEHU0223 income statement (TTM)
Revenue	€0
Cost of Revenue	€27.94k
Gross Profit	-€27.94k
Other Expenses	€3.05m
Earnings	-€3.08m

Last Reported Earnings

Mar 31, 2023

Next Earnings Date

Feb 22, 2024

Earnings per share (EPS)	-0.22
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	146.0%

How did BONEHU0223 perform over the long term?

See historical performance and comparison

BBS-Bioactive Bone Substitutes Oyj HLSE:BONEHU0223 Stock Report